What does BAUPHAR do?

BAUPHAR is a pharmacy in Rebecq. Public Limited, started on 22 December 2005, 1 establishment.

What is the address of BAUPHAR?

The registered office of BAUPHAR is located at Route de Quenast 15, 1430 Rebecq.

Is BAUPHAR still active?

Yes. According to the CBE (29 October 2026) BAUPHAR is active, legal situation “Normale toestand”, started on 22 December 2005.

Is BAUPHAR registered on Peppol?

Yes, BAUPHAR is registered on the Peppol network with ID 0208:0878246017.

What is the enterprise number of BAUPHAR?

The enterprise number of BAUPHAR is BE0878246017.

When was BAUPHAR founded?

BAUPHAR was founded on 22 December 2005.

Who are the directors of BAUPHAR?

According to the 2025 annual accounts, the directors of BAUPHAR are: ADV PHARMA SRL, CAROLINE DE VRIESE.

Is BAUPHAR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 December 2005; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did BAUPHAR make in 2025?

BAUPHAR posted a profit after taxes of € 220,648 in financial year 2025.

What is the revenue of BAUPHAR?

As a small company, BAUPHAR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 590,404.

How much does an employee at BAUPHAR earn?

The average wage cost per full-time employee at BAUPHAR was € 55,100 in 2025: staff costs of € 275,739 for 5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does BAUPHAR have?

According to the 2025 annual accounts, BAUPHAR has 5 full-time equivalents (FTE).

BAUPHAR (Public Limited) - Rebecq - BE0878246017

Dossier BAUPHAR, printed on 29 October 2026 from databakkes.be/en/0878246017/bauphar. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

BAUPHAR from Rebecq, company number BE0878246017, closed financial year 2025 with a result of € 220,648 after tax. For that financial year BAUPHAR recorded a gross margin of € 590,404 and equity of € 326,271. Compared with financial year 2024, the result moved from € 91,747 to € 220,648. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.

What it is worth Growing

€ 326,271

▲ 59% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 220,648

▲ 140% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 104,592

▼ 7% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

45 % of the profit went to the shareholders, mostly to ADV Pharma (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

▼ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 275,739

▼ 19% vs 2024

€ 55,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 36,981

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 216,072

▼ 14% vs 2024

€ 38,520 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 208,327

▲ 7% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 50,709

▼ 12% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 535,530 Gross margin 2022: € 535,530 First fiscal year in the series	€ 546,050 Gross margin 2023: € 546,050 ▲ 2% vs 2022 (€ 535,530) Favourable step	€ 505,652 Gross margin 2024: € 505,652 ▼ 7% vs 2023 (€ 546,050) Unfavourable step	€ 590,404 Gross margin 2025: € 590,404 ▲ 17% vs 2024 (€ 505,652) Favourable step	▲ 17%
Profit after taxes	€ 287,459 Profit after taxes 2022: € 287,459 First fiscal year in the series	€ 266,797 Profit after taxes 2023: € 266,797 ▼ 7% vs 2022 (€ 287,459) Unfavourable step	€ 91,747 Profit after taxes 2024: € 91,747 ▼ 66% vs 2023 (€ 266,797) Unfavourable step	€ 220,648 Profit after taxes 2025: € 220,648 ▲ 140% vs 2024 (€ 91,747) Favourable step	▲ 140%
Equity	€ 237,078 Equity 2022: € 237,078 First fiscal year in the series	€ 213,875 Equity 2023: € 213,875 ▼ 10% vs 2022 (€ 237,078) Unfavourable step	€ 205,623 Equity 2024: € 205,623 ▼ 4% vs 2023 (€ 213,875) Unfavourable step	€ 326,271 Equity 2025: € 326,271 ▲ 59% vs 2024 (€ 205,623) Favourable step	▲ 59%
Total debts	€ 1,117,359 Total debts 2022: € 1,117,359 First fiscal year in the series	€ 1,181,952 Total debts 2023: € 1,181,952 ▲ 6% vs 2022 (€ 1,117,359) Unfavourable step	€ 942,855 Total debts 2024: € 942,855 ▼ 20% vs 2023 (€ 1,181,952) Favourable step	€ 916,536 Total debts 2025: € 916,536 ▼ 3% vs 2024 (€ 942,855) Favourable step	▼ 3%
Cash	€ 261,809 Cash 2022: € 261,809 First fiscal year in the series	€ 332,418 Cash 2023: € 332,418 ▲ 27% vs 2022 (€ 261,809) Favourable step	€ 112,657 Cash 2024: € 112,657 ▼ 66% vs 2023 (€ 332,418) Unfavourable step	€ 104,592 Cash 2025: € 104,592 ▼ 7% vs 2024 (€ 112,657) Unfavourable step	▼ 7%
Land & buildings	€ 120,952 Land & buildings 2022: € 120,952 First fiscal year in the series	€ 107,513 Land & buildings 2023: € 107,513 ▼ 11% vs 2022 (€ 120,952) Unchanged	€ 94,074 Land & buildings 2024: € 94,074 ▼ 12% vs 2023 (€ 107,513) Unchanged	€ 80,635 Land & buildings 2025: € 80,635 ▼ 14% vs 2024 (€ 94,074) Unchanged	▼ 14%
Retained profit	€ 107,078 Retained profit 2022: € 107,078 First fiscal year in the series	€ 83,875 Retained profit 2023: € 83,875 ▼ 22% vs 2022 (€ 107,078) Unfavourable step	€ 75,623 Retained profit 2024: € 75,623 ▼ 10% vs 2023 (€ 83,875) Unfavourable step	€ 196,271 Retained profit 2025: € 196,271 ▲ 160% vs 2024 (€ 75,623) Favourable step	▲ 160%
Dividend	€ 250,000 Dividend 2022: € 250,000 First fiscal year in the series	€ 290,000 Dividend 2023: € 290,000 ▲ 16% vs 2022 (€ 250,000) Unchanged	€ 100,000 Dividend 2024: € 100,000 ▼ 66% vs 2023 (€ 290,000) Unchanged	€ 100,000 Dividend 2025: € 100,000 Unchanged (€ 100,000) Unchanged
Bank debt	€ 262,572 Bank debt 2022: € 262,572 First fiscal year in the series	€ 258,774 Bank debt 2023: € 258,774 ▼ 1% vs 2022 (€ 262,572) Favourable step	€ 250,382 Bank debt 2024: € 250,382 ▼ 3% vs 2023 (€ 258,774) Favourable step	€ 216,072 Bank debt 2025: € 216,072 ▼ 14% vs 2024 (€ 250,382) Favourable step	▼ 14%
Balance sheet total	€ 1,354,438 Balance sheet total 2022: € 1,354,438 First fiscal year in the series	€ 1,395,827 Balance sheet total 2023: € 1,395,827 ▲ 3% vs 2022 (€ 1,354,438) Unchanged	€ 1,148,478 Balance sheet total 2024: € 1,148,478 ▼ 18% vs 2023 (€ 1,395,827) Unchanged	€ 1,242,806 Balance sheet total 2025: € 1,242,806 ▲ 8% vs 2024 (€ 1,148,478) Unchanged	▲ 8%
Employees (FTE)	3.6 Employees (FTE) 2022: 3.6 First fiscal year in the series	4.1 Employees (FTE) 2023: 4.1 ▲ 0.5 vs 2022 (3.6) Unchanged	5.6 Employees (FTE) 2024: 5.6 ▲ 1.5 vs 2023 (4.1) Unchanged	5 Employees (FTE) 2025: 5 ▼ 0.6 vs 2024 (5.6) Unchanged	▼ 0.6

Key figures of BAUPHAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BAUPHAR?

What happened at BAUPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 19, 2026 New annual accounts for financial year 2025: profit of € 220,648 (▲ 140% vs 2024). Source: NBB ↗
2016 CAROLINE DE VRIESE became a director. NBB
2011 ADV PHARMA SRL became a director. NBB
Jan 31, 2006 New establishment in Rebecq. KBO
Dec 22, 2005 Start of the company according to the CBE. KBO

In short

From € 287,459 profit in 2022 to € 220,648 profit in 2025.

Paid € 140,495 in corporate taxes since 2022.

Best year ever: 2022, with € 287,459 profit.

On average € 118,100 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

ADV Pharma 100%

The stake of ADV Pharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

BAUPHAR

Behind BAUPHAR are ADV PHARMA SRL and CAROLINE DE VRIESE. The shares are held by ADV Pharma (100%).

Directors

According to the 2025 annual accounts

ADV PHARMA SRL

Managing director · represented by ALINE DE VRIESE

Also active at: LA PHARMACIE DE VRIESE, MEDI - PREST, La Pharmacie de Saintes

since 2011

CAROLINE DE VRIESE

Managing director

Also active at: LA PHARMACIE DE VRIESE, MEDI - PREST, ADV Pharma, La Pharmacie de Saintes

since 2016

Shareholders

ADV Pharma

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Route de Quenast 15

1430 Rebecq

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

FJA

ADV Pharma same network

€ 426,155 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0878.246.017

VAT number

BE 0878.246.017

Registered office

Route de Quenast 15, 1430 Rebecq

Names & denominations

BAUPHAR

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

22 December 2005

Peppol

Active · Active since 10 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

BAUPHAR

Financials

What happened to BAUPHAR?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions